See in this edition of Life Sciences & Healthcare Newsletter:
-
ANVISA Opens Public Consultation for Review of RDC on Cannabis Products
-
CFF and CFM in Legal Dispute Over Prescription of Medications
-
ANVISA Opens Public Consultation on Over-the-Counter Medications
-
ANVISA Approves New Measures for Control of GLP-1 Agonist Medications
-
ANVISA Opens Public Consultation on Sanitary Control of Airports and Aircraft
-
CMED Opens Public Consultation on Pricing of New Products and Presentations
To check out the full content, please click here.
